FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

María José Galindo

Research Profile

Disorders

Procedures

Chemicals & Drugs

Geographic Areas

Spain

Concepts & Ideas

Living Beings

Physiology

Drug Resistance, Multiple, Viral

Activities & Behaviors

Patient Compliance

Co-author Network

Publications

TOP 3
Juan Berenguer; Ana Carrero; María José Galindo; Gabriel Gaspar; Juan González-García; Josep M Guardiola; Juan J Jusdado; José López Aldeguer; Josep Mallolas; María Luisa Montes; Enrique Ortega; Federico Pulido; Carmen Quereda; Rafael Rubio; Ignacio Santos; José Sanz; María J Téllez; Cristina Tural; Eva Van Den Eynde; Miguel A Von Wichmann; Julio Alvarez-Pellicer; Elena Barquilla; Carlos Barros; José M Bellón
Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virus.
Nicolás Merchante; Esperanza Merino; Carlos Mínguez; Enrique Ortega; Sergio Padilla; Concepción Amador; Marcial Delgado-Fernández; María José Galindo; Francisco Jover; José López Aldeguer; Manuel Márquez-Solero; Joaquín Portilla; Maria José Ríos-Villegas; Antonio Rivero; Alberto Romero-Palacios; Francisco Téllez; Juan A Pineda
Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain.
Juan Berenguer; Herminia Esteban; María José Galindo; Gabriel Gaspar; Juan González-García; Josep M Guardiola; Antoni Jou; Juan J Jusdado; José López Aldeguer; Josep Mallolas; Pilar Miralles; María Luisa Montes; Enrique Ortega; Federico Pulido; Carmen Quereda; Elena Rodríguez; Rafael Rubio; Ignacio Santos; José Sanz; María J Téllez; Eva Van Den Eynde; Miguel A Von Wichmann; Carlos Barros; José M Bellón
Sustained virological response to interferon plus ribavirin reduces non-liver-related mortality in patients coinfected with HIV and Hepatitis C virus.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of María José Galindo (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Juan Berenguer; Ana Carrero; María José Galindo; Gabriel Gaspar; Juan González-García; Josep M Guardiola; Juan J Jusdado; José López Aldeguer; Josep Mallolas; María Luisa Montes; Enrique Ortega; Federico Pulido; Carmen Quereda; Rafael Rubio; Ignacio Santos; José Sanz; María J Téllez; Cristina Tural; Eva Van Den Eynde; Miguel A Von Wichmann; Julio Alvarez-Pellicer; Elena Barquilla; Carlos Barros; José M Bellón
Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virus.
Journal of hepatology 2013;58(6):1104-12.
2013: Nicolás Merchante; Esperanza Merino; Carlos Mínguez; Enrique Ortega; Sergio Padilla; Concepción Amador; Marcial Delgado-Fernández; María José Galindo; Francisco Jover; José López Aldeguer; Manuel Márquez-Solero; Joaquín Portilla; Maria José Ríos-Villegas; Antonio Rivero; Alberto Romero-Palacios; Francisco Téllez; Juan A Pineda
Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2013;56(1):143-50.
2012: Juan Berenguer; Herminia Esteban; María José Galindo; Gabriel Gaspar; Juan González-García; Josep M Guardiola; Antoni Jou; Juan J Jusdado; José López Aldeguer; Josep Mallolas; Pilar Miralles; María Luisa Montes; Enrique Ortega; Federico Pulido; Carmen Quereda; Elena Rodríguez; Rafael Rubio; Ignacio Santos; José Sanz; María J Téllez; Eva Van Den Eynde; Miguel A Von Wichmann; Carlos Barros; José M Bellón
Sustained virological response to interferon plus ribavirin reduces non-liver-related mortality in patients coinfected with HIV and Hepatitis C virus.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;55(5):728-36.
2012: José R Santos; Jonathan M Schapiro; Bonaventura Clotet; Pere Domingo; María José Galindo; Arkaitz Imaz; José A Iribarren; Josep M Llibre; Ana Mariño; Celia Miralles; Santiago Moreno; Arelly Ornelas
Mutations in the protease gene associated with virological failure to lopinavir/ritonavir-containing regimens.
The Journal of antimicrobial chemotherapy 2012;67(6):1462-9.
2011: Vicente Estrada; Manuel Fuentes-Ferrer; María José Galindo; Myriam Garrido; Paloma Geijo; José López Aldeguer; Fernando Lozano; Agustín Muñoz; Josefa Muñoz-Sánchez; Enric Pedrol; Teresa Puig; Esteve Ribera; Bernardino Roca; María Rodrigo; Trinitario Sánchez; María Luisa García Alcalde; Manuel Castaño-Carracedo; Jaime Cosín; Elisabeth Deig; Pere Domingo; Ramón Teira; Alberto Terrón; Antonio Vergara; Pompeyo E. Viciana; Francisco Vidal; Ignacio Suárez-Lozano
Dyslipidaemia in HIV-infected women on antiretroviral therapy. Analysis of 922 patients from the Spanish VACH cohort.
BMC women's health 2011;11():36.
2008: Josep M Llibre; A Bonjoch; J Iribarren; María José Galindo; Eugenia Negredo; Pere Domingo; N Pérez-Alvarez; J Martinez-Picado; J Schapiro; Bonaventura Clotet
Targeting only reverse transcriptase with zidovudine/lamivudine/abacavir plus tenofovir in HIV-1-infected patients with multidrug-resistant virus: a multicentre pilot study.
HIV medicine 2008;9(7):508-13.
2008: Josep M Llibre; Pere Domingo; Miguel A del Pozo; Celia Miralles; María José Galindo; Isabel Viciana; Santiago Moreno; Jonathan M Schapiro; Bonaventura Clotet
Long-distance interactive expert advice in highly treatment-experienced HIV-infected patients.
The Journal of antimicrobial chemotherapy 2008;61(1):206-9.
2007: Marina Núñez; Celia Miralles; Miguel Angel Berdún; Elena Losada; Koldo Aguirrebengoa; Antonio Ocampo; Piedad Arazo; Manuel Cervantes; Ignacio de Los Santos; Isabel San Joaquín; Santiago Echeverría; María José Galindo; Victor Asensi; Pablo Barreiro; Julio Sola; Juan José Hernandez-Burruezo; Josep Maria Guardiola; Miriam Romero; Javier García-Samaniego; Vincent Soriano
Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial.
AIDS research and human retroviruses 2007;23(8):972-82.
2007: Marina Núñez; Ana Mariño; Angel Mariño; Celia Miralles; Miguel Angel Berdún; Julio Sola; Juan José Hernandez-Burruezo; María José Galindo; Pablo Barreiro; Luz Martin-Carbonero; Vincent Soriano
Baseline serum hepatitis C virus (HCV) RNA level and response at week 4 are the best predictors of relapse after treatment with pegylated interferon plus ribavirin in HIV/HCV-coinfected patients.
Journal of acquired immune deficiency syndromes (1999) 2007;45(4):439-44.
2007: Rosa Polo; Carmen Gómez-Candela; C Miralles; Jaime Locutura; J Alvarez; F Barreiro; D Bellido; E Câncer; D Cánoves; P Domingo; Vicente Estrada; Carmina R Fumaz; María José Galindo; T García-Benayas; C Iglesias; JA Irles; Inmaculada Jiménez-Nacher; F Lozano; I Marqués; J R Martínez-Alvarez; M J Mellado; A Miján; José Tomás Ramos; P Riobo
Recommendations from SPNS/GEAM/SENBA/SENPE/AEDN/SEDCA/GESIDA on nutrition in the HIV-infected patient.
Nutrición hospitalaria : organo oficial de la Sociedad Española de Nutrición Parenteral y Enteral 2007;22(2):229-43.
2007: Rosario Palacios; Francisco Jiménez-Oñate; Manuela Aguilar; María José Galindo; Pablo Rivas; Antonio Ocampo; Juan Berenguer; Jose Alberto Arranz; Maria José Ríos; Hernando Knobel; Francisco Moreno; Javier Ena; Jesús Santos
Impact of syphilis infection on HIV viral load and CD4 cell counts in HIV-infected patients.
Journal of acquired immune deficiency syndromes (1999) 2007;44(3):356-9.
2007: Vincent Soriano; Celia Miralles; Miguel Angel Berdún; Elena Losada; Koldo Aguirrebengoa; Antonio Ocampo; Piedad Arazo; Manuel Cervantes; Ignacio de los Santos; Isabel San Joaquín; Santiago Echeverria; María José Galindo; Victor Asensi; Pablo Barreiro; Julio Sola; Juan José Hernandez-Burruezo; Josep Maria Guardiola; Francisco Blanco; Luz Martin-Carbonero; Javier García-Samaniego; Marina Nuñez
Premature treatment discontinuation in HIV/HCV-coinfected patients receiving pegylated interferon plus weight-based ribavirin.
Antiviral therapy 2007;12(4):469-76.
2007: Rosario Palacios; María José Galindo; J A Arranz; Fernando Lozano; Vicente Estrada; Antonio Rivero; D Morales; Victor Asensi; A del Arco; A Muñoz; Jesús Santos
Cervical lipomatosis in HIV-infected patients: a case-control study.
HIV medicine 2007;8(1):17-21.
2005: Hernando Knobel; Ismael Escobar; Rosa Polo; Luis Ortega; M Teresa Martín-Conde; José L Casado; Carles Codina; Josefina Fernández; María José Galindo; Olatz Ibarra; Monserrat Llinas; Celia Miralles; Melcior Riera; Carmina R Fumaz; Aurea Segador; Ferran Segura; Lourdes Chamorro
[Recommendations from GESIDA/SEFH/PNS to improve adherence to antiviral treatment (2004)].
Enfermedades infecciosas y microbiología clínica 2005;23(4):221-31.
2005: Ramón Teira; Ignacio Suárez-Lozano; Pepa Muñoz; Pompeyo E. Viciana; Fernando Lozano; María José Galindo; Alberto Terrón; Antonio Vergara; Paloma Geijo; José R Arribas; Jaime Cosín; Pere Domingo; Esteban Ribera; Bernardino Roca; M Luisa García-Alcalde; Trinitario Sánchez; Agustín Muñoz-Sanz
[Changing trends in HIV epidemics: recent diagnoses in the Spanish VACH cohort (2000-2002)].
Enfermedades infecciosas y microbiología clínica 2005;23(4):213-7.
2004: Sergio Reus; Joaquín Portilla; Adelina Gimeno; José Sánchez Payá; J A García-Henarejos; Onofre Martínez-Madrid; Jordi Usó; Bernardino Roca; María José Galindo; José López Aldeguer
[Predictors of progression and death in patients with advanced HIV infection in the era of highly active antiretroviral therapy].
Enfermedades infecciosas y microbiología clínica 2004;22(3):142-9.
2004: Ismael Escobar; Hernando Knobel; Rosa Polo; L Ortega; M Teresa Martín-Conde; José L Casado; Carles Codina; J Fernández; María José Galindo; O Ibarra; M Llinas; Celia Miralles; M Riera; Carmina R Fumaz; A Segador; Ferran Segura; Lourdes Chamorro
[GESIDA/SEFH/PNS recommendations to improve adherence to antiretroviral therapy in 2004].
Farmacia hospitalaria : órgano oficial de expresión científica de la Sociedad Española de Farmacia Hospitalaria 2004;28(6 Suppl 1):6-18.
2003: Ana Barrios; Carmen de Mendoza; Luz Martín-Carbonero; Esteban Ribera; Pere Domingo; María José Galindo; Juan Gálvez; Vicente Estrada; David Dalmau; Victor Asensi; Vincent Soriano
Role of baseline human immunodeficiency virus genotype as a predictor of viral response to tenofovir in heavily pretreated patients.
Journal of clinical microbiology 2003;41(9):4421-3.
2003: Bernardino Roca; Ignacio Suarez; Juan Gonzalez; Myriam Garrido; Belen de la Fuente; Ramon Teira; Paloma Geijo; Jaime Cosin; Salvador Perez-Cortes; María José Galindo; Fernando Lozano; Pere Domingo; Pompeyo E. Viciana; Esteban Ribera; Antonio Vergara; Trinitario Sánchez
Hepatitis C virus and human immunodeficiency virus coinfection in Spain.
The Journal of infection 2003;47(2):117-24.
2002: Ignacio Suárez-Lozano; José M Fajardo; Myriam Garrido; Bernardino Roca; M Luisa García-Alcalde; Paloma Geijo; Daniel Selma; Fernando Lozano; Ramón Teira; Pompeyo E. Viciana; Salvador Pérez-Cortés; Pere Domingo; Antonia Menchero; María José Galindo; Jaime Cosín; Esteban Ribera; José R Arribas; Juan R Lacalle
Epidemiological trends of HIV infection in Spain: preventative plans have to be oriented to new target populations (Spanish VACH Cohort).
AIDS (London, England) 2002;16(18):2496-9.